COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 952: Articles 9511-9520  | Next

In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate
Touret, F., Baronti, C., Bouzidi, H. S., de Lamballerie, X.
10.1101/2022.01.01.474639 — Posted: 2022-01-03
Omicron variant escapes therapeutic mAbs contrary to eight prior main VOC
Boschi, C., Colson, P., Bancod, A., Moal, V., La Scola, B.
10.1101/2022.01.03.474769 — Posted: 2022-01-03
An in vitro and in vivo approach for the isolation of Omicron variant from human clinical specimens
Yadav, P. D., Gupta, N., Potdar, V., Mohandas, S., Sahay, R. R., Sarkale, P., Shete, A. M., Razdan, A., Patil, D. Y., Nyayanit, D. A., Joshi, Y., Patil, S., Majumdar, T., Dighe, H., Malhotra, B., Shastri, J., Abraham, P.
10.1101/2022.01.02.474750 — Posted: 2022-01-03
RG203KR mutations in SARS-CoV-2 Nucleocapsid: Assessing the impact using Virus-like particle model system
Raheja, H., Das, S., Banerjee, A., P, D., C, D., Mukhopadhyay, D., Ramachandra, S. G., Das, S.
10.1101/2022.01.02.473343 — Posted: 2022-01-03
Nonself Mutations in the Spike Protein Suggest an Increase in the Antigenicity and a Decrease in the Virulence of the Omicron Variant of SARS-CoV-2
Otaki, J. M., Nakasone, W., Nakamura, M.
10.1101/2021.12.30.474613 — Posted: 2022-01-03
SARS-CoV-2 entry sites are present in all structural elements of the human glossopharyngeal and vagal nerves: clinical implications
Mezey, E., Vitale-Cross, L., Szalayova, I., Scoggins, A., Palkovits, M.
10.1101/2021.12.30.474580 — Posted: 2022-01-03
Robust expansion of phylogeny for fast-growing genome sequence data
Ye, Y., Shum, M., Tsui, J., Yu, G., Smith, D., Zhu, H., Wu, J., Guan, Y., Lam, T. T.-Y.
10.1101/2021.12.30.474610 — Posted: 2022-01-03
Reduced Pathogenicity of the SARS-CoV-2 Omicron Variant in Hamsters
McMahan, K., Giffin, V., Tostanoski, L., Chung, B., Siamatu, M., Suthar, M., Halfmann, P., Kawaoka, Y., Piedra-Mora, C., Martinot, A., Kar, S., Andersen, H., Lewis, M. G., Barouch, D. H.
10.1101/2022.01.02.474743 — Posted: 2022-01-03 Discussion: Onsite
Analysis of SARS-CoV-2 Omicron Neutralization Data up to 2021-12-22
Netzl, A., Tureli, S., LeGresley, E., Mühlemann, B., Wilks, S. H., Smith, D. J.
10.1101/2021.12.31.474032 — Posted: 2022-01-03
The efficacy of Andrographis paniculata (Burm.f.) Wall. ex Nees crude extract in hospitalised mild COVID-19 patients: a retrospective cohort study
Tanwettiyanont, J., Piriyachananusorn, N., Sangsoi, L., Boonsong, B., Sunpapoa, C., Tanamatayarat, P., Kanchanasurakit, S., Na-Ek, N.
10.1101/2022.01.01.22268609 — Posted: 2022-01-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).